Clinical Fungal Infections

A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Fungal Pathogens".

Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 152

Special Issue Editor


E-Mail Website
Guest Editor
Department of Cell Biology, Institute of Biological Sciences, University of Brasília, Brasília, Brazil
Interests: innate immunity; fungal infections

Special Issue Information

Dear Colleagues,

Human clinical fungal infections are caused by a wide range of fungi, which can be both primary and opportunistic pathogens. These infections can affect a wide range of individuals. However, these fungi are more likely to cause severe disease in people with weakened immune systems. Fungal infections that are not life-threatening, such as skin, nail, or vaginal yeast infections, are common. Some infections can be more severe as systemic mycosis. Common clinical fungal infections include candidiasis, aspergillosis, histoplasmosis, cryptococcosis, and blastomycosis. Recently, some opportunistic fungal infections have occurred concomitantly with SARS-CoV-2 infection. The increasing incidence of fungal infections, the modulation of the host immune response, and the rise in drug resistance to currently used clinical and environmental antifungals challenge our public health systems. We, therefore, propose this Special Issue with a specific focus on new advances in the field.

We look forward to your valuable contributions to this Special Issue.  

Prof. Dr. Anamélia Lorenzetti Bocca
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • fungal infections
  • invasive fungal infections
  • human fungal infections
  • clinical fungal infections
  • primary and opportunistic pathogens

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop